文献速递泌尿生殖腹部MR

基于MRI的影像组学预测前列腺癌分级分组:诊断试验准确性系统综述与Meta分析

MRI-based Radiomics for Predicting Prostate Cancer Grade Groups: A Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies.
PubMed 文献 · Acad Radiol · 2024-12-31

该系统综述与Meta分析共纳入43项研究、9983例患者,评估MRI影像组学预测前列腺癌分级分组(GG)的准确性,以组织病理学为参考标准。患者层面分析显示GG≥2、GG≥3、GG≥4的AUC分别为0.93、0.91、0.93;病灶层面分析GG≥2和GG≥3的AUC分别为0.84和0.89。影像组学模型在排除和确认GG方面能力中等,存在显著异质性。

要点

  • 患者层面分析预测GG≥2、GG≥3、GG≥4的AUC分别为0.93、0.91、0.93
  • 病灶层面分析预测GG≥2和GG≥3的AUC分别为0.84和0.89
  • 影像组学模型在排除和确认GG方面能力中等

核心结论

  • 影像组学似乎是一种准确的无创工具,可用于预测前列腺癌分级分组,并能提升标准诊断方法的性能,从而增强临床决策。

研究设计与样本

  • 系统综述与诊断试验准确性Meta分析,遵循PRISMA-DTA指南,检索Web of Sciences、PubMed、Scopus和Embase数据库,纳入采用MRI衍生影像组学预测GG并以组织病理学评估为参考标准的研究,共43项研究、9983例患者,使用QUADAS-2和METRICS工具进行质量评估。

诊断标准与关键数值

  • 患者层面分析:预测GG≥2的AUC为0.93,预测GG≥3的AUC为0.91,预测GG≥4的AUC为0.93
  • 病灶层面分析:预测GG≥2的AUC为0.84,预测GG≥3的AUC为0.89
  • 合并估计了敏感度、特异度、似然比、诊断比值比和AUC
  • 采用Cochran Q检验和I平方检验评估异质性,采用Deek漏斗图评估发表偏倚
  • 采用Fagan列线图和似然比散点图评估临床适用性

临床应用与阅片要点

  • 作者认为影像组学似乎是一种准确的无创工具,可用于预测前列腺癌分级分组。
  • 作者认为影像组学能提升标准诊断方法的性能,从而增强临床决策。
  • 影像组学模型在排除和确认GG方面能力中等。

局限性

  • 观察到显著异质性,并通过Meta回归确定了异质性来源。
  • 影像组学模型在排除和确认GG方面能力仅为中等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Prostate cancer (PCa) is the second most common cancer among men and a leading cause of cancer-related mortalities. Radiomics has shown promising performances in the classification of PCa grade group (GG) in several studies. Here, we aimed to systematically review and meta-analyze the performance of radiomics in predicting GG in PCa.

MATERIALS AND METHODS: Adhering to PRISMA-DTA guidelines, we included studies employing magnetic resonance imaging-derived radiomics for predicting GG, with histopathologic evaluations as the reference standard. Databases searched included Web of Sciences, PubMed, Scopus, and Embase. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) and METhodological RadiomICs Score (METRICS) tools were used for quality assessment. Pooled estimates for sensitivity, specificity, likelihood ratios, diagnostic odds ratio, and area under the curve (AUC) were calculated. Cochran's Q and I-squared tests assessed heterogeneity, while meta-regression, subgroup analysis, and sensitivity analysis addressed potential sources. Publication bias was evaluated using Deek's funnel plot, while clinical applicability was assessed with Fagan nomograms and likelihood ratio scattergrams.

RESULTS: Data were extracted from 43 studies involving 9983 patients. Radiomics models demonstrated high accuracy in predicting GG. Patient-based analyses yielded AUCs of 0.93 for GG≥2, 0.91 for GG≥3, and 0.93 for GG≥4. Lesion-based analyses showed AUCs of 0.84 for GG≥2 and 0.89 for GG≥3. Significant heterogeneity was observed, and meta-regression identified sources of heterogeneity. Radiomics model showed moderate power to exclude and confirm the GG.

CONCLUSION: Radiomics appears to be an accurate noninvasive tool for predicting PCa GG. It improves the performance of standard diagnostic methods, enhancing clinical decision-making.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Lomer NB, Ashoobi MA, Ahmadzadeh AM, et al. MRI-based Radiomics for Predicting Prostate Cancer Grade Groups: A Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies. Acad Radiol. 2024. PMID: 39743477. doi:10.1016/j.acra.2024.12.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。